• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Urogen Pharma(URGN.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Nov7
UroGen Pharma Reports Q3 Results and Launches ZUSDURI
05:57
Nov6
Urogen Pharma released FY2025 Q3 earnings on November 6 Pre-Market (EST), actual revenue USD 27.48 M (forecast USD 32.47 M), actual EPS USD -0.6938 (forecast USD -0.68)
14:30
Urogen Pharma released FY2025 9-month earnings on November 6 Pre-Market EST, actual revenue USD 71.95 M, actual EPS USD -2.6645
14:30
UroGen Pharmaceuticals Reports Preliminary Results of UGN-103 Clinical Trial
12:58
Oct30
Urogen Pharma to Release FY2025 Q3 Earnings on November 6 Pre-Market EST, Forecast Revenue USD 32.47 M, EPS USD -0.6928
00:08
Oct24
Gershell covers healthcare stocks and gives Urogen Pharma target price
13:32

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 27.48 M, Net Income -33.35 M, EPS -0.6938

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 24.22 M, Net Income -49.94 M, EPS -1.046

May12
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 20.25 M, Net Income -43.84 M, EPS -0.9245

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
9.530
+132.44%
+5.430
ANGH
3.770
+62.50%
+1.450
WTO
1.020
+61.09%
+0.387
ESHAR
0.2500
+47.06%
+0.080
NCL
0.2731
+40.77%
+0.079
FGMCR
0.5500
+33.50%
+0.138
ESHA
19.180
+33.38%
+4.800
IPEXR
0.8000
+31.97%
+0.194
RDACR
0.2400
+26.32%
+0.050
DVLT
0.6521
+26.25%
+0.136
View More